South San Francisco, CA March 6, 2019 Genentech Press Release FDA Accepts Genentech’s Supplemental New Drug Application for Xofluza (baloxavir marboxil) for the Treatment of Influenza in People at High Risk of Complications — XOFLUZA would be the first antiviral…